Algo version: 0.98b
Chemclin Diagnostics Co., is listed at the SHH Exchange
Chemclin Diagnostics Co., [688468.SS]
SHH Sector: Healthcare Industry:Medical - Diagnostics & Research

Is Chemclin Diagnostics Co., stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Chemclin Diagnostics Co., pays dividends. Last time was Friday 14th of June 2024 where the investors holding the stock on Friday 14th of June 2024 were paid CNY0.125 per share. Over the last 3 times between 2022 and 2024, Chemclin Diagnostics Co., has paid CNY0.642 with an average of CNY0.21 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Chemclin Diagnostics Co., 10 years ago, but if you had invested on Friday 9th of April 2021 when the price was CNY24.94, you would have made a loss of CNY-18.26 per share or -73.22%

Yes, the average daily trading liquidity for Chemclin Diagnostics Co., is CNY4.02 million. You should therefore be able to get in and out of your positions relatively fast.

Chemclin Diagnostics Co., has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.82, the company's ability to pay off the debt is good. Chemclin Diagnostics Co., has a very good net profit margin of 32.73% and should have very high tolerances against inflation.

We have calculated the inflation risk for Chemclin Diagnostics Co., to be low [0.15 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.09 and is down -0.37 over the last 30 days.